| Serial Number | 79428897 |
| Word Mark | FILLUNAR |
| Filing Date | Tuesday, May 13, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, January 7, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Antiseptic preparations; medical hyaluronic acid in ampoule form for pharmaceutical purposes; drug delivery agents in the form of lyophilized formulations for the treatment of facial wrinkles and volume enhancement; medical preparations for the treatment of skin wrinkles and facial volume loss using drug delivery systems; chemicals for pharmaceutical use, namely, for skin wrinkles and facial volume loss using drug delivery systems; cells for medical purposes; reagents for medical use; pharmaceutical preparations for the treatment of skin wrinkles and facial volume loss using drug delivery systems; diagnostic preparations for medical purposes; medical anti-aging serum; medical skin grafts (including viscous fillers for wrinkle filling or volume augmentation); nucleic acid for medical purposes; medical hyaluronic acid preparations for pharmaceutical purposes; pharmaceutical skin lotions; pharmaceutical preparations for skin wrinkles and facial volume loss using drug delivery systems; surgical transplants comprising living tissues; pharmaceutical preparations for the treatment and prevention of skin wrinkles and facial volume loss using drug delivery systems; natural biomaterials for tissue recovery for medical purposes; pharmaceutical preparations for the treatment of wrinkles; injectable medical preparations for wrinkle filling in the form of gels; injectable dermal fillers for the treatment of wrinkles in the form of gels; injectable dermal fillers; injectable pharmaceuticals for treatment of skin wrinkles and facial volume loss using drug delivery systems; injectable dermal fillers for the treatment of forehead, glabellar lines, temple, cheeks, cheekbones, nasolabial folds, marionette lines, lip lines; pharmaceutical preparation for skin care; bandages for skin wounds; pharmaceutical preparation for scar treatment |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 31, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BIONT Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Event Date | Event Description |
| Thursday, July 31, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, August 5, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 5, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, September 25, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, October 1, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, October 2, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, November 20, 2025 | REFUSAL PROCESSED BY MPU |
| Thursday, November 20, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, December 5, 2025 | REFUSAL PROCESSED BY IB |
| Wednesday, January 7, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 7, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 7, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |